Software/ platforms

Partnership Between Biopharma Software Genedata and SCIEX Deepens

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process.

SCIEX, a global leader in life science analytical technologies, and Genedata, leading provider of biopharma enterprise software solutions, have entered into a strategic partnership to develop new software solutions for the biopharmaceutical mass spectrometry market. The goal of this partnership is to jointly innovate new workflows that leverage the proven Genedata Expressionist enterprise software platform and the analytical power of new SCIEX hardware such as the ZenoTOF 7600 system. This smart integration of software and hardware will allow biopharma customers to characterize progressively more complex molecules with increased speed and confidence, ultimately allowing them to accelerate the development of life-changing drugs.

“Genedata Expressionist has become the software solution of choice for the characterization and quality monitoring of innovative biotherapeutics and related applications such as host cell protein analysis at many of the world’s leading biopharma organizations,” stated Othmar Pfannes, Ph.D., CEO of Genedata. “While we remain fully committed to supporting all instrument vendors, partnering at a strategic level is a logical next step to deliver tomorrow’s technology sooner to our joint customers. This will ultimately accelerate discovery, development, and commercialization of novel biopharmaceuticals, while reducing costs by streamlining and automating complex analytical processes.”

“Our customers tell us that the future of biotherapeutics lies in the development of next-generation therapies such as mAb variants, including multi-specific antibodies,” said Mani Krishnan, Vice President, and General Manager, CE & Biopharma, at SCIEX. “However, they also tell us the complexity of these molecules presents a significant characterization challenge in both analytics and data processing. This strategic partnership with Genedata will enable the development of customized data processing workflows to address key customer challenges, so that therapies can progress through the development pipeline faster.”

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.

Related posts

Panaya Test Dynamix Named Leader in Test Management Software

PR Newswire

Immersive Labs Raises $75m to Accelerate Data Platform

Business Wire

Applied Digital Announces Second AI Cloud Service Customer

GlobeNewswire